BRIEF published on 12/04/2025 at 16:01, 14 hours 4 minutes ago Vanguard Group's Disclosure on Qualcomm Securities Securities Form 8.3 Disclosure Vanguard Group Qualcomm
BRIEF published on 12/04/2025 at 16:00, 14 hours 5 minutes ago Vanguard Discloses Stake in American Axle & Manufacturing Takeover Code Vanguard Group Stake Disclosure Share Transactions American Axle
BRIEF published on 12/04/2025 at 15:58, 14 hours 6 minutes ago The Vanguard Group, Inc. Discloses Interest in JTC plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure JTC Plc
BRIEF published on 12/04/2025 at 15:57, 14 hours 7 minutes ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 12/04/2025 at 15:56, 14 hours 9 minutes ago The Vanguard Group Discloses Stake in Greencore Group plc Takeover Code Vanguard Group Stake Equity Disclosure Greencore Group
PRESS RELEASE published on 12/04/2025 at 15:56, 14 hours 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.82% ownership in Qualcomm Incorporated. Purchase and sale of USD 0.0001 common stock announced The Vanguard Group Stock Purchase Ownership Disclosure Stock Sale Qualcomm Incorporated
BRIEF published on 12/04/2025 at 15:55, 14 hours 10 minutes ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Disclosure Takeover Code Vanguard Group Shareholding Bluefield Solar
PRESS RELEASE published on 12/04/2025 at 15:55, 14 hours 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.50% ownership in American Axle & Manufacturing Holdings, Inc. Form 8.3 filing on 03 Dec 2025 Form 8.3 Financial Filing Vanguard Group Ownership Disclosure American Axle
PRESS RELEASE published on 12/04/2025 at 15:53, 14 hours 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc as of 03 December 2025. Details on securities holdings and transactions provided in Form 8.3 Securities Transactions Form 8.3 Vanguard Group JTC Plc
BRIEF published on 12/04/2025 at 15:53, 14 hours 11 minutes ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Takeover Code Vanguard Group Spire Healthcare Shareholding Disclosure
Published on 12/05/2025 at 02:35, 3 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 35 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 40 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 50 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 21 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 4 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
